VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NDRA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NDRAENDRA Life Sciences Inc.
$4.95$4M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNDRAQuarterly Financials

ENDRA Life Sciences Inc. (NDRA) Quarterly Financials

120+ quarters historyFree accessUpdated daily

ENDRA Life Sciences Inc. (NDRA) quarterly income statement — complete revenue, gross profit & net income history

NDRA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold39.72K0000000000000000000
COGS % of Revenue--------------------
Gross Profit-39.72K0000000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses2.13M1.62M1.37M1.3M1.47M4.3M1.51M2.23M2.78M1.46M3.13M2.99M2.94M3.31M3.42M3.57M2.86M3.07M2.65M3.2M
OpEx % of Revenue--------------------
Selling, General & Admin1.4M1.11M938.59K920.03K940.6K3.66M714.57K1.51M1.74M878.43K1.5M1.59M1.55M1.65M1.59M1.72M1.64M1.65M1.48M1.46M
SG&A % of Revenue--------------------
Research & Development776.41K508.14K432.11K381.06K528.68K637.96K794.44K716.37K1.04M579.35K1.63M1.4M1.39M1.66M1.83M1.85M1.21M1.42M1.17M1.74M
R&D % of Revenue--------------------
Other Operating Expenses-39.72K0000000000000000000
Operating Income-2.17M-1.62M-1.37M-1.3M-1.47M-4.3M-1.51M-2.23M-2.78M-1.46M-3.13M-2.99M-2.94M-3.31M-3.42M-3.57M-2.86M-3.07M-2.65M-3.2M
Operating Margin %--------------------
Operating Income Growth %-47.95%62.25%9.17%41.68%47.16%-194.75%51.77%25.5%5.4%56%8.43%16.16%-2.94%-7.87%-28.92%-11.61%-10.85%-36.25%18.58%-10.68%
EBITDA-2.13M-1.58M-1.33M-1.27M-1.42M-4.25M-1.46M-2.18M-2.72M-1.4M-3.06M-2.92M-2.87M-3.25M-3.36M-3.52M-2.8M-3.02M-2.59M-3.14M
EBITDA Margin %--------------------
EBITDA Growth %-49.89%62.77%8.5%41.84%47.75%-204.35%52.43%25.36%5%56.97%8.93%16.9%-2.33%-7.55%-29.72%-11.98%-10.93%-38.24%20.03%-10.07%
D&A (Non-Cash Add-back)39.72K39.53K39.39K32.79K45.58K46.36K54.01K50.12K55.68K61.25K70.45K72.71K71.04K67.77K58.59K55.68K52.22K53.67K61.51K60.37K
EBIT-2.17M-1.62M-1.37M-1.3M-1.47M-4.3M-1.51M-2.23M-2.78M-1.46M-3.13M-2.99M-2.94M-3.31M-3.42M-3.57M-2.86M-3.1M-2.65M-3.2M
Net Interest Income000000-7.32M00000-3.42K0-23.01K-19.37K-2.86T000
Interest Income00000000000000000000
Interest Expense0000007.32M000003.42K023.01K19.37K2.86T000
Other Income/Expense862.32K-1.55M-225.26K75.18K432.95K147.74K-845.08K1.7K4.84K-1.76K28.23K437.43K-3.42K23.79K-23.01K-19.37K-2.93K-33.09K-7.51K1.09K
Pretax Income-1.31M-3.17M-1.6M-1.23M-1.04M-4.15M-2.35M-2.23M-2.78M-1.46M-3.1M-2.56M-2.94M-3.29M-3.44M-3.59M-2.86M-3.1M-2.66M-3.2M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-1.31M-3.17M-1.6M-1.23M-1.04M-4.15M-2.35M-2.23M-2.78M-1.46M-3.1M-2.56M-2.94M-3.29M-3.44M-3.59M-2.86M-3.1M-2.66M-3.2M
Net Margin %--------------------
Net Income Growth %-26.55%23.62%32.2%45.01%62.66%-184.27%24.08%12.83%5.68%55.63%9.87%28.79%-2.96%-5.96%-29.42%-12.25%-25.95%-37.94%18.41%-10.55%
Net Income (Continuing)-1.31M-3.17M-1.6M-1.23M-1.04M-4.15M-2.35M-2.23M-2.78M-1.46M-3.1M-2.56M-2.94M-3.29M-3.44M-3.59M-2.86M-3.1M-2.66M-3.2M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-1.09-3.26-2.10-1.71-1.86-7.73-2.10-1.31-1.63-0.85-1.82-1.50-1.53-1.69-1.79-1.87-999999.00-1.48-1.27-1.54
EPS Growth %41.4%57.83%0%-30.53%-14.11%-809.41%-15.38%12.67%-6.54%49.7%-1.68%19.79%100%-14.19%-40.94%-21.43%-99999900%21.28%53.48%60.81%
EPS (Basic)-1.09-3.26-2.10-1.71-1.86-7.73-2.10-1.31-1.63-0.85-1.82-1.50-1.53-1.69-1.79-1.87-999999.00-1.48-1.27-1.54
Diluted Shares Outstanding1.2M787.02K761.22K717.11K557.58K536.91K1.12M1.71M1.71M1.71M1.71M1.71M1.93M1.93M1.93M1.93M2.15M2.1M2.1M2.08M
Basic Shares Outstanding1.2M787.02K761.22K717.11K557.58K536.91K1.12M1.71M1.71M1.71M1.71M1.71M1.93M1.93M1.93M1.93M2.15M2.1M2.1M2.08M
Dividend Payout Ratio--------------------